Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Syndros® (dronabinol) – Schedule change
May 25, 2017 – The FDA approved changes to the scheduling for Syndros (dronabinol), from CX to CII, as per the Federal register notice dated March 23, 2017.
